Kira Pharmaceuticals is a clinical-stage, global biotechnology company pioneering a world free from complement disease. Enabled by its LOGIC platform, the company has developed a robust pipeline of nine (9) novel complement assets focused on validated targets across the complement cascade. With an experienced team of complement biology experts, drug developers, protein engineers and leaders from across the pharma and biotech industry, Kira Pharmaceuticals is uniquely positioned to tackle some of the most complex and toughest challenges in the complement space and to deliver first-in-class and best-in-class therapies to transform the lives of patients. The company is headquartered in Cambridge, Massachusetts with offices in Suzhou and Shanghai, China, and Australia.
Company Details
- Employees
- 23
- Founded
- 2017
- Address
- Cambridge, Ma, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.kirapharma.com
- HQ
- Cambridge, MA
Kira Pharmaceuticals Questions
Kira Pharmaceuticals's website is http://www.kirapharma.com
Kira Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/kira-pharmaceuticals
Kira Pharmaceuticals has
23 employees.
View email and phone details for 23
employees at Kira Pharmaceuticals.
Kira Pharmaceuticals's industry is
Biotechnology Research
Kira Pharmaceuticals's top competitors are
Xione Therapeutics, Inc.,
Acrivon Therapeutics, Inc.,
Engage Scientific,
Nimbus Therapeutics,
Beam Therapeutics,
Curie.bio,
Pelage Pharmaceuticals,
Kymera Therapeutics,
Alnylam Pharmaceuticals,
Larkspur Biosciences.
Kira Pharmaceuticals's categories are Biotechnology Research
Kira Pharmaceuticals's founding year is 2017
